The Nigeria Centre for Disease Control and Prevention (NCDC) has confirmed a total of 807 suspected cases of cerebrospinal meningitis (CSM) and 74 fatalities across 22 states as of March 26, 2025. The Case Fatality Rate (CFR) currently stands at 9.2%.
NCDC Deploys Rapid Response Teams to Affected States
In response to the outbreak, NCDC has mobilized its Rapid Response Teams (RRT) to Kebbi, Sokoto, and Katsina states, which have recorded the highest number of suspected cases and fatalities. The agency disclosed this in an official statement titled “CSM Outbreak: NCDC Rapid Response Teams in Kebbi, Sokoto, and Katsina States,” signed by its Head of Corporate Communication, Sani Datti.
Rising Cases and Affected Regions
According to the NCDC, the outbreak has impacted multiple states, including:
- Northwest & Northeast: Kebbi, Katsina, Jigawa, Yobe, Gombe, Adamawa, Borno
- North Central: Benue, Niger, Plateau, FCT
- Southwest & Southeast: Oyo, Osun, Anambra, Ebonyi, Ekiti
- South-South: Ondo, Akwa Ibom, Bayelsa
Kebbi, Katsina, and Sokoto states have reported the most severe cases, with a relatively low rate of sample collection, making urgent intervention crucial.
Government’s Response and Safety Measures
NCDC Director General, Dr. Jide Idris, emphasized that the deployed teams, which include specialists in case management and lumbar puncture techniques, will remain in affected areas for an initial 14-day period, with extensions if necessary.
Dr. Idris also highlighted key response objectives:
- Rapid containment of the outbreak
- Enhanced case management and infection prevention control (IPC)
- Strengthened surveillance and sample collection
- Community engagement and risk communication
- Investigation of outbreak sources and public health recommendations
The NCDC reiterated its commitment to collaborating with state governments and partners to curb the spread of CSM and protect public health.
Public Health Advisory
Health authorities urge Nigerians to adopt preventive measures, including early medical consultation for symptoms, vaccination, and adherence to hygiene protocols.
